Patent · US Active

Compound for use against pathogenic Neisseria and Haemophilus species and Moraxella catarrhalis

US11596626B2 · kind B2 · utility

0Cited by

3References

17Claims

0Family size

Assignee

University of Konstanz · DE

Inventors

Thomas Böttcher · Maisach, DE
David Szamosvari · Konstanz, DE
Christof Hauck · Konstanz, DE
Tamara Schuhmacher · Konstanz, DE
Petra Muenzner-Voight · Konstanz, DE

Key dates

Filing date	Dec 14, 2018
Grant date	Mar 7, 2023
Priority date	—
Expiry date	Apr 14, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D215/233
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a compound, which can be used in the prevention and treatment of infections with pathogenic Neisseria species, in particular N. gonorrhoeae and N. meningitidis (the gonococcus and the meningococcus, respectively), and other pathogenic bacteria (e.g. Haemophilus species or Moraxella catarrhalis), and which can be used for disinfecting a substrate from said bacteria. Moreover, the present invention relates to a corresponding pharmaceutical composition comprising said compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.